Bryan S. Riley, PhD U.S. FDA

Bryan Riley is a Branch Chief in the Division of Microbiology Assessment in the Office of Pharmaceutical Quality, Center for Drug Evaluation and Research at the Food and Drug Administration. He is also a member of the CDER/OPQ Emerging Technology Team which is entrusted with facilitating the adoption of innovative technologies for pharmaceutical manufacturing. Prior to coming to FDA in 1998, he directed a clinical microbiology laboratory specializing in molecular diagnostic methods. He holds B.S. and M.S. degrees in Microbiology from Texas Tech University and a Ph.D. in Microbiology from the University of North Texas. He completed his formal scientific training as a post-doctoral fellow at the University of Texas Southwestern Medical Center at Dallas.